| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/14/1998 | WO1998009647A3 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 05/14/1998 | WO1998006861A3 Delivery of tolerogenic antigens via edible plants or plant-derived products |
| 05/14/1998 | WO1998006427A3 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 05/14/1998 | WO1998004286A3 Assembly-deficient herpesvirus vaccine |
| 05/14/1998 | WO1998001558A3 Protein and peptide vaccines for inducing mucosal immunity |
| 05/14/1998 | WO1998000174A3 Method of preparing a composite bone graft |
| 05/14/1998 | DE19640817A1 Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1 A recombinant preparation process for a complete malaria antigen gp190 / MSP 1 |
| 05/14/1998 | CA2271235A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses |
| 05/14/1998 | CA2270922A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens |
| 05/14/1998 | CA2270909A1 Novel histamine h2 receptor |
| 05/14/1998 | CA2270869A1 Constrained helical peptides and methods of making same |
| 05/14/1998 | CA2270867A1 Hepatocyte growth factor antagonists |
| 05/14/1998 | CA2270288A1 Human monoclonal antibodies |
| 05/14/1998 | CA2270282A1 Novel coding sequences from herpes simplex virus type-2 |
| 05/14/1998 | CA2270173A1 Tumor-associated kazal inhibitor with pec-60 homology |
| 05/14/1998 | CA2270153A1 Methods for identifying genes essential to the growth of an organism |
| 05/14/1998 | CA2269757A1 Structure of secretory immunoglobulin a |
| 05/14/1998 | CA2269647A1 Human squalene epoxidase |
| 05/14/1998 | CA2264610A1 Branched peptide linkers |
| 05/13/1998 | EP0841399A2 Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor |
| 05/13/1998 | EP0841396A1 Human telomerase catalytic subunit |
| 05/13/1998 | EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses |
| 05/13/1998 | EP0841392A2 Attenuated live neospora vaccine |
| 05/13/1998 | EP0841067A1 Freeze-dried preparation containing monoclonal antibody |
| 05/13/1998 | EP0840796A2 Mucosal delivery of polynucleotides |
| 05/13/1998 | EP0840794A1 Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells |
| 05/13/1998 | EP0840791A2 Generation of immune responses to prostate-specific antigen (psa) |
| 05/13/1998 | EP0840789A2 Transketolase-related protein |
| 05/13/1998 | EP0840785A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor |
| 05/13/1998 | EP0840750A1 Ha-2 antigenic peptide |
| 05/13/1998 | EP0840749A1 The h-y antigen |
| 05/13/1998 | EP0840747A1 Papillomavirus polyprotein constructs |
| 05/13/1998 | EP0840620A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 05/13/1998 | EP0840618A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies |
| 05/13/1998 | EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 05/13/1998 | EP0707494B1 Bloody swine dysentery vaccine and vaccination kit therefor |
| 05/13/1998 | EP0573614B1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| 05/13/1998 | EP0406286B1 Dna encoding a ryegrass pollen allergen |
| 05/13/1998 | CN1181761A Antigen compsn. against mycoplasma |
| 05/13/1998 | CN1181705A Gel form of a vaccine |
| 05/12/1998 | US5750503 Administering synergistic mixture of granulocyte colony stimulating factor (g-csf) and tumor necrosis factor binding protein (tnf-bp) lacking first domain of constant region of heavy chain of human immunoglobulin igg1 or igg3 |
| 05/12/1998 | US5750398 Vector, element and method for inhibiting immune recognition |
| 05/12/1998 | US5750395 DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides |
| 05/12/1998 | US5750391 Filariid nematode cysteine protease proteins |
| 05/12/1998 | US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus |
| 05/12/1998 | US5750369 DNA encoding a prostaglandin F28 receptor, a host cell transformed therewith and an expression product thereof |
| 05/12/1998 | US5750366 Cloning and expression of gonadotropin-releasing hormone receptor |
| 05/12/1998 | US5750350 Kit containing antibodies |
| 05/12/1998 | US5750332 Peptomers with enhanced immunogenicity |
| 05/12/1998 | US5750119 Immunotherapeutic stress protein-peptide complexes against cancer |
| 05/12/1998 | US5750118 Deactivated serpulina antigen |
| 05/12/1998 | US5750116 Haemophilus influenzae pilus vaccines |
| 05/12/1998 | US5750115 Veterinary medicine |
| 05/12/1998 | US5750114 Glycosylated glycoprotein d polypeptide |
| 05/12/1998 | US5750113 An isolated infectious bronchitis virus (ibv) of the same serotype as that of the ibv strain 4/91 deposit; attenuation |
| 05/12/1998 | US5750112 Canine coronavirus vaccine from feline enteric coronavirus |
| 05/12/1998 | US5750111 Mild newcastle disease virus vaccine |
| 05/12/1998 | US5750110 Vaccine composition containing adjuvants |
| 05/12/1998 | US5750109 Gene coding; neutralization antigen |
| 05/12/1998 | US5750102 Double transfectants of the MHC genes as cellular vaccines for immuno prevention of tumor metastasis |
| 05/12/1998 | US5750101 Puncturing at longitudinal midline over the egg's air cell in order to administer vaccine in egg's albumin end; hatching |
| 05/07/1998 | WO1998018945A1 Reagents and methods useful for detecting diseases of the breast |
| 05/07/1998 | WO1998018933A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
| 05/07/1998 | WO1998018931A2 Streptococcus pneumoniae polynucleotides and sequences |
| 05/07/1998 | WO1998018930A2 Streptococcus pneumoniae antigens and vaccines |
| 05/07/1998 | WO1998018928A1 Immunogenic detoxified mutant e. coli lt-a toxin |
| 05/07/1998 | WO1998018924A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 05/07/1998 | WO1998018921A1 NEUTROKINE $g(a) |
| 05/07/1998 | WO1998018919A2 Gabaa receptor subunit epsilon-related protein |
| 05/07/1998 | WO1998018917A2 RIBOFLAVIN MUTANTS AS VACCINES AGAINST $i(ACTINOBACILLUS PLEUROPNEUMONIAE) |
| 05/07/1998 | WO1998018916A1 Human p2x purinoreceptor |
| 05/07/1998 | WO1998018825A1 Anti-p53 single-chain antibody fragments and their uses |
| 05/07/1998 | WO1998018821A1 Vaccines against pathogens characterized by serological cross-reaction but lacking cross-protection |
| 05/07/1998 | WO1998018819A1 Purification of respiratory syncytial virus antigens |
| 05/07/1998 | WO1998018818A2 Hepatitis b inhibitors |
| 05/07/1998 | WO1998018812A1 Oligomers which inhibit the expression of interleukin genes |
| 05/07/1998 | WO1998018810A1 Immunostimulatory nucleic acid molecules |
| 05/07/1998 | WO1998018453A1 Oral vaccines for young animals with an enteric coating |
| 05/07/1998 | WO1998018324A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
| 05/07/1998 | WO1998018323A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 05/07/1998 | WO1998006851A3 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS) |
| 05/07/1998 | WO1998006841A3 Two human nsp-like proteins |
| 05/07/1998 | WO1998006746A3 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 05/07/1998 | WO1998006248A3 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 05/07/1998 | WO1997046683A3 Polynucleotides encoding secreted proteins |
| 05/07/1998 | WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/07/1998 | DE19645559A1 Pharmazeutische Antigen-/Antikörperpräparation Pharmaceutical antigen / antibody preparation |
| 05/07/1998 | CA2665133A1 Neutrokine .alpha. |
| 05/07/1998 | CA2271720A1 Streptococcus pneumoniae polynucleotides and sequences |
| 05/07/1998 | CA2270401A1 Novel hepatitis b virus inhibitors |
| 05/07/1998 | CA2270345A1 Immunostimulatory nucleic acid molecules |
| 05/07/1998 | CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/07/1998 | CA2269722A1 Oligomers which inhibit the expression of interleukin genes |
| 05/07/1998 | CA2269663A1 Streptococcus pneumoniae antigens and vaccines |
| 05/07/1998 | CA2269213A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
| 05/07/1998 | CA2268750A1 Human p2x purinoreceptor |
| 05/07/1998 | CA2268023A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 05/07/1998 | CA2265523A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 05/07/1998 | CA2241626A1 Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae |
| 05/06/1998 | EP0839915A1 Secretory immunoglobulin A as a mucosal vaccine delivery system |